- CEO
- Gyung-Mok Yeo
- Full Time Employees
- 137
- Sector
- Consumer non-durables
- Industry
- Food: specialty/candy
- Address
- Cheongju-si South Korea
- IPO Date
- Dec 29, 2016
- Business
- S&D Co., Ltd. is a South Korea-based company engaged in the research, development, manufacturing, and distribution of functional food materials, seasoning bases, natural extracts, and health functional food ingredients. Founded in 1998 and headquartered in Cheongju, South Korea, the company operates primarily across two business divisions: General Functional Food Materials and Health Functional Food Materials. The company's core product portfolio includes seasoning bases, composite savory seasonings, liquid and powder sauce ingredients, natural flavorings, yeast extracts, and dehydrated meat and seafood concentrates utilized in processed foods such as instant noodles, snacks, soups, and convenience foods; standardized botanical and natural extracts for nutraceutical and dietary supplement applications, including Ecklonia cava extract for sleep support, Fagopyritol for blood glucose regulation, Xanthorrhizol for antibacterial and oral health, Rubus coreanus extract, rice bran extracts, and Panduratin and Lindera glauca extracts for metabolic and skin health; and custom ingredient formulation, extraction, concentration, spray drying, and blending services adhering to ISO 22000, ISO 14001, ISO 45001, HACCP, and Halal standards. S&D Co., Ltd. serves prominent domestic and multinational food and beverage manufacturers, including Samyang Foods, Nongshim, CJ CheilJedang, and Pulmuone, acting as the key supplier of sauce and flavoring bases for leading global food brands such as the Buldak ramen series. In recent developments, the company initiated and completed a KRW 16 billion capital investment to expand its Food Science Center Plant 2 and modernize production facilities in Cheongju, bringing the expanded facilities into full commercial operation to increase total sauce and composite material production capacity by more than 50% to approximately 35,000 metric tons annually. Additionally, the company has broadened its bioactive natural substance pipeline by commercializing next-generation functional extracts aimed at sleep enhancement and metabolic health, scaling its manufacturing infrastructure to support growing export volumes and expanding client requirements across Asia, North America, and European markets.